Qidong Yixin Granule for preventing atrial fibrillation after ablation
Part of Heart & circulation clinical trials.
This trial tests whether a traditional Chinese medicine granule, Qidong Yixin, can help prevent atrial fibrillation from coming back after a heart ablation procedure. It is for people with persistent atrial fibrillation who have not had good results from other heart rhythm medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have persistent atrial fibrillation (not just occasional episodes) and have tried at least one heart rhythm drug that didn't work well
- You are scheduled to have your first heart ablation procedure
- You do not have heart valve problems causing your atrial fibrillation
- Your heart's pumping function is at least 40% and your left atrium is not too large (less than 55mm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if acupuncture can help prevent atrial fibrillation (an irregular heart rhythm) from coming back after a procedure called catheter ablation. If you have had ablation and your heart rhythm is back to normal, this study may help you stay in a healthy rhythm.
This trial tests a Chinese herbal medicine called Qishen Granules for people with heart failure who still have a normal pumping ability (ejection fraction 50% or higher). It may help reduce symptoms and improve heart function.
This study tests a modified 'pills-in-the-pocket' approach—taking antiarrhythmic drugs only when symptoms occur—for people with non-valvular atrial fibrillation (AF) who still have arrhythmias lasting over 24 hours after their first catheter ablation. It aims to see if this strategy can safely control symptoms without needing daily medication.
This study tests whether ezetimibe, a cholesterol-lowering medication, can help prevent atrial fibrillation (an irregular heartbeat) from coming back after a procedure called catheter ablation. If you are scheduled for your first ablation for persistent atrial fibrillation, this trial may help you maintain a normal heart rhythm.
This trial tests whether ondansetron can help people with atrial fibrillation (an abnormal heart rhythm) around the time of elective catheter ablation. It may improve the safety or effectiveness of the procedure by targeting a pathway involved in heart rhythm events.
This trial tests a step-by-step treatment plan for people with persistent atrial fibrillation (a type of irregular heartbeat) who live in Southwest China. The goal is to find a better way to manage and possibly fix this heart condition.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.